The Spring 2023 issue features a Therapeutic Spotlight on Neuroscience focusing on why post-covid-19 cognitive impairment is a new target for drug development.

Other features in the Spring issue include: 

• • • A market report on the US drug discovery sector 
    • Whether AI can craft new medicines 
    • Why digital biomarkers will power tomorrow's Alzheimer's therapies